FDMT
FDMT
US35104E1001
4D Molecular Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 85.209.000 37.000
230194.6%
Cost of Revenue -- --
--
Gross Profit -- --
--
244.756.000 187.878.000
30.3%
Operating Income -159.547.000 -187.841.000
15.1%
Pretax Income -140.109.000 -160.868.000
12.9%
Net Income Common Stockholders -140.109.000 -160.868.000
12.9%
-- --
--
-- --
--
ende